Evidence map›Paper›PMID 27030542›Full record

ArticleScientific reports2016

Transplantation of Defined Populations of Differentiated Human Neural Stem Cell Progeny.

Jeff M Fortin, Hassan Azari, Tong Zheng, Roya P Darioosh, Michael E Schmoll, Vinata Vedam-Mai, Loic P Deleyrolle, Brent A Reynolds

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Review
  3. Wrap it up: myelination of transplanted neurons for repair.Frontiers in cellular neuroscience · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jeff M FortinDepartment of Neurosurgery, McKnight Brain Institute, University of Florida, Gainesville, FL 32610-0261, USA.
Hassan AzariDepartment of Neurosurgery, McKnight Brain Institute, University of Florida, Gainesville, FL 32610-0261, USA.
Tong ZhengDepartment of Neurosurgery, McKnight Brain Institute, University of Florida, Gainesville, FL 32610-0261, USA.
Roya P DariooshDepartment of Neurosurgery, McKnight Brain Institute, University of Florida, Gainesville, FL 32610-0261, USA.
Michael E SchmollDepartment of Neurosurgery, McKnight Brain Institute, University of Florida, Gainesville, FL 32610-0261, USA.
Vinata Vedam-MaiDepartment of Neurosurgery, McKnight Brain Institute, University of Florida, Gainesville, FL 32610-0261, USA.
Loic P DeleyrolleDepartment of Neurosurgery, McKnight Brain Institute, University of Florida, Gainesville, FL 32610-0261, USA.
Brent A ReynoldsDepartment of Neurosurgery, McKnight Brain Institute, University of Florida, Gainesville, FL 32610-0261, USA.

Funding

Using social networks to map and evaluate team science across CTSA hubsUL1TR001427 · NCATS · UNIVERSITY OF FLORIDA · PI MITCHELL, DUANE A. · 2015 to 2024
$37.2M
NCATS NIH HHS UL1 TR001427
6 · The paper itself

Abstract

Many neurological injuries are likely too extensive for the limited repair capacity of endogenous neural stem cells (NSCs). An alternative is to isolate NSCs from a donor, and expand them in vitro as transplantation material. Numerous groups have already transplanted neural stem and precursor cells. A caveat to this approach is the undefined phenotypic distribution of the donor cells, which has three principle drawbacks: (1) Stem-like cells retain the capacity to proliferate in vivo. (2) There is little control over the cells' terminal differentiation, e.g., a graft intended to replace neurons might choose a predominantly glial fate. (3) There is limited ability of researchers to alter the combination of cell types in pursuit of a precise treatment. We demonstrate a procedure for differentiating human neural precursor cells (hNPCs) in vitro, followed by isolation of the neuronal progeny. We transplanted undifferentiated hNPCs or a defined concentration of hNPC-derived neurons into mice, then compared these two groups with regard to their survival, proliferation and phenotypic fate. We present evidence suggesting that in vitro-differentiated-and-purified neurons survive as well in vivo as their undifferentiated progenitors, and undergo less proliferation and less astrocytic differentiation. We also describe techniques for optimizing low-temperature cell preservation and portability.

Indexed as

Stem Cell TransplantationAnimalsCell DifferentiationCell ProliferationCell SurvivalCell TrackingCryopreservationGene ExpressionGenes, ReporterGreen Fluorescent ProteinsHumansImmunomagnetic SeparationInjections, IntraventricularMiceMice, Inbred NODMice, SCIDGreen Fluorescent Proteins

Identifiers

PMID27030542
PMCPMC4814839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.